Therapeutic potential of digitoflavone on diabetic nephropathy: Nuclear factor erythroid 2-related factor 2-dependent anti-oxidant and anti-inflammatory effect

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Yang, Yang ^a   Chen, Gang ^a   Cheng, Xiaolan ^a   Teng, Zhiying ^a   Cai, Xueting ^a   Yang, Jie ^a   Sun, Xiaoyan ^a   Lu, Wuguang ^a   Wang, Xiaoning ^a   Yao, Yuanzhang ^a   Hu, Chunping ^a   Cao, Peng ^a  

^a Jiangsu Province Academy of Traditional Chinese Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; FLAVONE DERIVATIVE; NFE2L2 PROTEIN, MOUSE; SCLEROPROTEIN; TGFB1 PROTEIN, MOUSE; TRANSCRIPTION FACTOR NRF2; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL; BIOSYNTHESIS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; MESANGIUM; METABOLISM; MOUSE; PATHOLOGY; TRANSFORMED CELL LINE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE, TRANSFORMED; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; EXTRACELLULAR MATRIX PROTEINS; FLAVONES; GENE EXPRESSION REGULATION; GLOMERULAR MESANGIUM; MICE; NF-E2-RELATED FACTOR 2; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84937933743     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep12377     Document Type: Article

References (43)

1. Lozano, R. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2095-2128 (2012).
2. Debnam, E. S. & Unwin, R. J. Hyperglycemia and intestinal and renal glucose transport: implications for diabetic renal injury. Kidney Int 50, 1101-1109 (1996).
3. Sassy-Prigent, C. et al. Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Diabetes 49, 466-475 (2000).
4. Banba, N. et al. Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy. Kidney Int 58, 684-690 (2000).
5. Okada, S. et al. Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes. Diabetes 52, 2586-2593 (2003).
6. Chow, F., Ozols, E., Nikolic-Paterson, D. J., Atkins, R. C. & Tesch, G. H. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int 65, 116-128 (2004).
7. Gaede, P., Poulsen, H. E., Parving, H. H. & Pedersen, O. Double-blind, randomised study of the effect of combined treatment with vitamin C and E on albuminuria in Type 2 diabetic patients. Diabet Med 18, 756-760 (2001).
8. Fridlyand, L. E. & Philipson, L. H. Oxidative reactive species in cell injury: Mechanisms in diabetes mellitus and therapeutic approaches. Ann N Y Acad Sci 1066, 136-151 (2005).
9. Rivero, A. et al. Pathogenic perspectives for the role of inflammation in diabetic nephropathy. Clin Sci (Lond) 116, 479-492 (2009).
10. Navarro-Gonzalez, J. F., Mora-Fernandez, C., Muros de Fuentes, M. & Garcia-Perez, J. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat Rev Nephrol 7, 327-340 (2011).
11. Chen, X. L. et al. Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression. Am J Physiol Heart Circ Physiol 290, H1862-1870 (2006).
12. Jin, W. et al. Disruption of Nrf2 enhances upregulation of nuclear factor-kappaB activity, proinflammatory cytokines, and intercellular adhesion molecule-1 in the brain after traumatic brain injury. Mediators Inflamm 2008, 725174 (2008).
13. Itoh, K., Ishii, T., Wakabayashi, N. & Yamamoto, M. Regulatory mechanisms of cellular response to oxidative stress. Free Radic Res 31, 319-324 (1999).
14. Kensler, T. W., Wakabayashi, N. & Biswal, S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 47, 89-116 (2007).
15. Zhang, D. D. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab Rev 38, 769-789 (2006).
16. Jeong, W. S., Kim, I. W., Hu, R. & Kong, A. N. Modulatory properties of various natural chemopreventive agents on the activation of NF-kappaB signaling pathway. Pharm Res 21, 661-670 (2004).
17. Shen, G. et al. Chemoprevention of familial adenomatous polyposis by natural dietary compounds sulforaphane and dibenzoylmethane alone and in combination in ApcMin/+ mouse. Cancer Res 67, 9937-9944 (2007).
18. Xu, C., Shen, G., Chen, C., Gelinas, C. & Kong, A. N. Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells. Oncogene 24, 4486-4495 (2005).
19. Zoja, C., Benigni, A. & Remuzzi, G. The Nrf2 pathway in the progression of renal disease. Nephrol Dial Transplant 29 Suppl 1, i19-i24 (2014).
20. Jiang, T. et al. The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy. Diabetes 59, 850-860 (2010).
21. Zheng, H. et al. Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy. Diabetes 60, 3055-3066 (2011).
22. Neuhouser, M. L. Dietary flavonoids and cancer risk: evidence from human population studies. Nutr Cancer 50, 1-7 (2004).
23. Miean, K. H. & Mohamed, S. Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants. J Agric Food Chem 49, 3106-3112 (2001).
24. Gates, M. A. et al. A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer. Int J Cancer 121, 2225-2232 (2007).
25. Sun, T., et al. Antioxidant activities of different colored sweet bell peppers (Capsicum annuum L.). J Food Sci 72, S98-102 (2007).
26. Harborne, J. B. & Williams, C. A. Advances in flavonoid research since 1992. Phytochemistry 55, 481-504 (2000).
27. Cai, X. et al. Luteolin induced G2 phase cell cycle arrest and apoptosis on non-small cell lung cancer cells. Toxicol In Vitro 25, 1385-1391 (2011).
28. Cai, X. et al. The molecular mechanism of luteolin-induced apoptosis is potentially related to inhibition of angiogenesis in human pancreatic carcinoma cells. Oncol Rep 28, 1353-1361 (2012).
29. Cai, X. et al. Digitoflavone inhibits IkappaBalpha kinase and enhances apoptosis induced by TNFalpha through downregulation of expression of nuclear factor kappaB-regulated gene products in human pancreatic cancer cells. PLoS One 8, e77126 (2013).
30. Yang, Y. et al. Chemoprevention of dietary digitoflavone on colitis-associated colon tumorigenesis through inducing Nrf2 signaling pathway and inhibition of inflammation. Mol Cancer 13, 48 (2014).
31. Taneda, S. et al. Amelioration of diabetic nephropathy in SPARC-null mice. J Am Soc Nephrol 14, 968-980 (2003).
32. Ruiz, S., Pergola, P. E., Zager, R. A. & Vaziri, N. D. Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease. Kidney Int 83, 1029-1041 (2013).
33. Bondeva, T. & Wolf, G. Reactive oxygen species in diabetic nephropathy: friend or foe? Nephrol Dial Transplant 29, 1998-2003 (2014).
34. Lee, D. F. et al. KEAP1 E3 ligase-mediated downregulation of NF-kappaB signaling by targeting IKKbeta. Mol Cell 36, 131-140 (2009).
35. Wakabayashi, N., Slocum, S. L., Skoko, J. J., Shin, S. & Kensler, T. W. When NRF2 talks, who's listening? Antioxid Redox Signal 13, 1649-1663 (2010).
36. Aleksunes, L. M., Reisman, S. A., Yeager, R. L., Goedken, M. J. & Klaassen, C. D. Nuclear factor erythroid 2-related factor 2 deletion impairs glucose tolerance and exacerbates hyperglycemia in type 1 diabetic mice. J Pharmacol Exp Ther 333, 140-151 (2010).
37. Kwon, E. Y., Jung, U. J., Park, T., Yun, J. W. & Choi, M. S. Luteolin attenuates hepatic steatosis and insulin resistance through the interplay between the liver and adipose tissue in mice with diet-induced obesity. Diabetes 64, 1658-1669 (2015).
38. Plaisier, C. et al. Effects of cinnamaldehyde on the glucose transport activity of GLUT1. Biochimie 93, 339-344 (2011).
39. Tan, Y. et al. Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo. Diabetes 60, 625-633 (2011).
40. Kashihara, N., Haruna, Y., Kondeti, V. K. & Kanwar, Y. S. Oxidative stress in diabetic nephropathy. Curr Med Chem 17, 4256-4269 (2010).
41. Singh, D. K., Winocour, P. & Farrington, K. Oxidative stress in early diabetic nephropathy: fueling the fire. Nat Rev Endocrinol 7, 176-184 (2011).
42. Lim, A. K. & Tesch, G. H. Inflammation in diabetic nephropathy. Mediators Inflamm 2012, 146154 (2012).
43. Galkina, E. & Ley, K. Leukocyte recruitment and vascular injury in diabetic nephropathy. J Am Soc Nephrol 17, 368-377 (2006).